Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PALI Palisade Bio > Company Executives
PALI Palisade Bio
3.060
-0.380-11.05%
Post Mkt Price
3.0600.0000.00%
NamePositionSalaryService DateEducationAgeGenderUpdated
Mr. J. D. FinleyInterim Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer1.11M----65male10/14/2022
Dr. Herbert B. Slade, M.D.Chief Medical Officer------68male11/23/2022
Dr. Mary Ann Gray,PhDIndependent Director135.78K----69female04/21/2022
Dr. Cristina Csimma, Pharm.D.Independent Director143.47K----63female04/21/2022
Mr. Donald A. WilliamsIndependent Director131.59K----63male04/21/2022
Mr. Binxian WeiIndependent Director119.35K----52male04/21/2022
Ms. Stephanie DiazIndependent Director130.48K----56female04/21/2022
Dr. Robert J. TrenschelIndependent Director121.64K----60male04/21/2022
Company Overview More
Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.
CEO: Mr. J. D. Finley
Market: NASDAQ
Listing Date: 08/27/2007
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist